FMWA
BIIB icon

Forvis Mazars Wealth Advisors’s Biogen BIIB Stock Holding History

Forvis Mazars Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,093
Closed -$306K – 264
2021
Q1 		$306K Sell
1,093
-368
-25% -$99.2K 0.02% 222
2020
Q4 		$358K Buy
1,461
+627
+75% +$162K 0.02% 266
2020
Q3 		$237K Buy
+834
New +$233K 0.01% 287
2020
Q2 		– Sell
-722
Closed -$228K – 309
2020
Q1 		$228K Sell
722
-12
-2% -$3.64K 0.02% 258
2019
Q4 		$218K Buy
+734
New +$204K 0.02% 270
2018
Q4 		– Sell
-646
Closed -$228K – 226
2018
Q3 		$228K Buy
+646
New +$222K 0.02% 214
2018
Q1 		– Sell
-631
Closed -$201K – 236
2017
Q4 		$201K Buy
+631
New +$202K 0.02% 235
2016
Q4 		– Sell
-697
Closed -$218K – 204
2016
Q3 		$218K Sell
697
-244
-26% -$72.3K 0.03% 176
2016
Q2 		$228K Buy
941
+77
+9% +$20.3K 0.03% 172
2016
Q1 		$225K Buy
864
+115
+15% +$30.4K 0.04% 169
2015
Q4 		$229K Sell
749
-43
-5% -$12.4K 0.03% 166
2015
Q3 		$231K Buy
792
+48
+6% +$15.9K 0.04% 160
2015
Q2 		$301K Buy
744
+45
+6% +$18.1K 0.05% 142
2015
Q1 		$295K Buy
699
+72
+11% +$28.4K 0.04% 148
2014
Q4 		$213K Sell
627
-27
-4% -$8.73K 0.03% 149
2014
Q3 		$216K Hold
654
– – 0.04% 132
2014
Q2 		$206K Sell
654
-109
-14% -$32.8K 0.04% 137
2014
Q1 		$237K Hold
763
– – 0.04% 145
2013
Q4 		$213K Buy
+763
New +$197K 0.04% 148

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Forvis Mazars Wealth Advisors's BIIB Position: Q2 2021 in Review

Forvis Mazars Wealth Advisors sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,093 shares — an estimated $306K sold.

Forvis Mazars Wealth Advisors first reported a position in BIIB in Q4 2013 and held it in 19 quarters. The position peaked at $358K in Q4 2020. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Forvis Mazars Wealth Advisors reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Forvis Mazars Wealth Advisors sold 1,093 Biogen shares in Q2 2021, an estimated $306K.
  • Forvis Mazars Wealth Advisors first reported a position in Biogen in Q4 2013 and held it in 19 quarters.
  • Forvis Mazars Wealth Advisors's Biogen position peaked at $358K in Q4 2020.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q2 2021, filed 14 Jul 2021.